Virus News and Research

Latest Virus News and Research

First Parkinson’s gene therapy patient well after 1 year suggesting that the therapy is safe and effective

The first ever patient to have undergone gene therapy for Parkinson’s appears to have come through phase I without a hitch, suggesting that the therapy is safe and effective, reports Marina Murphy in Chemistry & Industry.

2 Sep 2004

World needs to commit more resources to treat people infected with HIV

Leaders of the International AIDS Vaccine Initiative (IAVI) have stressed that as the world commits more resources to treat people infected with HIV, it must also intensify efforts to develop a vaccine to prevent new infections and stop the continuing spread of the virus.

2 Sep 2004

Epimmune presents SIV vaccine study data showing control of virus despite the presence of viral mutations

Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.

31 Aug 2004

Major trends in AIDS research that the different research teams throughout the world are pursuing

The science will be presented during the conference which is taking place in Lausanne until September 1, 2004. The advances in fundamental research, notably through a better understanding of the complex processes of immune defence, HIV and the functioning of vaccines, promote the genesis and development of new vaccine candidates.

30 Aug 2004

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

The interim data, from 205 volunteers in clinical trials in Kenya, Uganda and the United Kingdom, show that DNA.HIVA and MVA.HIVA are generally safe and well tolerated. However, the candidates’ ability to elicit an anti-HIV cell-mediated immune response is poor, using currently accepted measures of immune response.

30 Aug 2004

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

At the opening ceremony of the Lausanne, Switzerland, AIDS VACCINE '04 conference, leaders in the field of AIDS vaccine research called for increased political and financial commitment to facilitate the development of preventive and therapeutic AIDS vaccines as a public health imperative in fighting HIV/AIDS.

30 Aug 2004

Scientists discover breakthrough method to treat neuronal diseases

What do stroke, epilepsy, head or spinal cord trauma, Parkinson’s disease and Alzheimer’s disease patients have in common? They all suffer from neuronal cell death brought about by the absence or malfunction of specific genes.

30 Aug 2004

Emergence of drug resistant influenza viruses more common than previously thought

Results of a small study from Japan in this week’s issue of THE LANCET suggest that the emergence of influenza viruses which are resistant to a widely used influenza drug may be more common than previously thought.

26 Aug 2004

U.S. plan for influenza pandemic response

The U.S. Department of Health & Human Services has unveiled the draft Pandemic Influenza Response and Preparedness Plan, which outlines a coordinated national strategy to prepare for and respond to an influenza pandemic.

26 Aug 2004

Chiron delays Fluvirin influenza virus vaccine shipments

Chiron has announced that, in conducting final internal release procedures for its Fluvirin(R) influenza virus vaccine, the company's quality systems have identified a small number of lots that do not meet product sterility specifications.

26 Aug 2004

FDA reinforces use of Sustiva in first-line HIV combination therapy

Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.

26 Aug 2004

Inevitable that H5N1 avian influenza viruses will be detected in pigs

Considering the widespread nature of the current H5N1 outbreak in Asia and the capability of influenza viruses to jump the species barriers, it is inevitable that H5N1 virus will be detected in some pigs.

26 Aug 2004

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

Young adults who attended day care or nursery school when they were children were more than a third less likely to develop Hodgkin's disease, according to a new study by Harvard School of Public Health researchers.

25 Aug 2004

West Nile Virus found in Alberta

Alberta's first West Nile virus positive bird of the 2004 season has been detected in Lethbridge. A mosquito pool and a horse in Southern Alberta have also tested positive for the virus.

25 Aug 2004

High-resolution images reveal the molecular rearrangements that rotavirus uses to break into cells

High-resolution images constructed by researchers at Children's Hospital Boston and Harvard Medical School reveal the molecular rearrangements that rotavirus – the most common cause of severe, dehydrating diarrhea and vomiting in children worldwide – uses to break into cells.

25 Aug 2004

Australian research giant begins trial of avian influenza vaccine

The trial vaccine utilises Imugene Limited's platform adenoviral vector technology to deliver the necessary genetic material to stimulate the birds' immune responses.

25 Aug 2004

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Virginia Commonwealth University researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients and in those with cirrhosis, which may help scientists predict a person’s risk of developing primary liver cancer.

25 Aug 2004

Virus News and Research

Latest Virus News and Research

First Parkinson’s gene therapy patient well after 1 year suggesting that the therapy is safe and effective

World needs to commit more resources to treat people infected with HIV

Epimmune presents SIV vaccine study data showing control of virus despite the presence of viral mutations

Major trends in AIDS research that the different research teams throughout the world are pursuing

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

Scientists discover breakthrough method to treat neuronal diseases

Emergence of drug resistant influenza viruses more common than previously thought

U.S. plan for influenza pandemic response

Chiron delays Fluvirin influenza virus vaccine shipments

FDA reinforces use of Sustiva in first-line HIV combination therapy

Inevitable that H5N1 avian influenza viruses will be detected in pigs

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

West Nile Virus found in Alberta

High-resolution images reveal the molecular rearrangements that rotavirus uses to break into cells

Australian research giant begins trial of avian influenza vaccine

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Gray matter in brain associated with language processing among people with a family history of dyslexia

Los Angeles County Health Department confirms third West Nile virus victim

Researchers have coaxed RNA to self-assemble into 3-D arrays

A new way of characterising biomolecules eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in